The best peptides for immune support, judged by evidence, are few, and none is proven to prevent infections in healthy people. Thymosin alpha-1 has the most human data and is sold in more than 30 countries as Zadaxin, but its biggest recent trial, in 1,106 sepsis patients, found no survival benefit.[3][8] LL-37 and thymalin have far weaker evidence. The interventions with strong evidence are not peptides: recommended vaccines and adequate sleep.[1][2]
“Immune support” is a vague marketing phrase. It can mean fewer colds, better vaccine responses, help during serious infection, or “boosting” immunity with age. This guide grades the main peptides against each of those goals. For related compounds, see the longevity and immune peptides hub.
Best peptides for immune support: evidence at a glance
| Peptide or approach | Evidence level | What was shown | FDA status | Our profile |
|---|---|---|---|---|
| Recommended vaccines | FDA-approved for this use | Prevent specific serious infections; schedule set by CDC[1] | Approved vaccines | — |
| Adequate sleep | Human studies | Under 6 hours raised cold risk about four-fold after virus exposure[2] | Not a drug | — |
| Thymosin alpha-1 | Human RCTs (mixed) | No survival benefit in sepsis or hospitalized COVID-19[8][9] | Not approved in US; advisers voted 17 to 4 against compounding[5] | Thymosin alpha-1 |
| LL-37 | Small human studies | Topical cream for leg ulcers, mixed results; no trials for immunity[10][11] | Not approved; FDA lists safety concerns[13] | LL-37 |
| Thymalin | Small human studies | Developer-run Russian studies, not independently confirmed[14] | Not approved in US | Thymalin |
| Thymulin | No evidence, marketing only | No published trials for immune support | Not approved | Thymulin |
Start with what works
Vaccines are the best-proven way to strengthen protection against specific infections, and CDC publishes an adult schedule by age that includes vaccines such as influenza, COVID-19, zoster (shingles) and pneumococcal vaccines.[1]
Sleep matters more than most supplements. In a 2015 experiment, 164 healthy adults wore sleep trackers for a week, then received a cold virus in nasal drops. Those who slept under five hours, or five to six hours, were about four times as likely to develop a cold as people sleeping more than seven hours.[2]
Thymosin alpha-1: the best-studied immune peptide
Thymosin alpha-1, also called thymalfasin, is a 28-amino-acid peptide first isolated from the thymus. Its maker reported approvals in more than 30 countries, mostly for hepatitis B and C and some cancers, and as an immune enhancer under local rules.[3]
How it performs depends on the goal:
- Vaccine response: in a 1989 trial, 90 men aged 65 to 99 received thymosin alpha-1 or placebo alongside a flu shot.[6] A 2012 pilot in dialysis patients reported better antibody responses to a pandemic flu vaccine.[7] Even so, FDA’s 2024 review concluded there was a lack of evidence for using it to improve vaccine responses.[4]
- Sepsis: the 2025 TESTS trial in 22 Chinese hospitals randomized 1,106 adults. Death within 28 days was 23.4% with thymosin alpha-1 and 24.1% with placebo, no meaningful difference.[8]
- COVID-19: a 2023 meta-analysis of 5,352 hospitalized patients found no effect on death and did not support its use.[9]
In the US, FDA reviewed it for about a dozen uses, from hepatitis to sepsis to ME/CFS, and found the evidence lacking, and its advisers voted 17 to 4 against adding it to the compounding list in December 2024.[4][5] It is generally well tolerated, with injection-site discomfort most common, but labels abroad advise against use in children and pregnancy and urge caution in autoimmune disease.[4]
LL-37: frontline defense, unproven as a supplement
LL-37 is the body’s own antimicrobial peptide, made in skin, airways and white blood cells, and active vitamin D directly switches on its gene.[12] Its human trials tested a cream on chronic leg ulcers. A 34-patient trial found the two lower doses sped healing,[10] but a larger 148-patient trial found no significant overall benefit.[11]
No trial has tested injected LL-37 for immunity. FDA lists it among substances with safety concerns, including immune reactions and impurities.[13] Excess LL-37 is also a T-cell target in many people with psoriasis.[15] Our thymosin alpha-1 vs LL-37 comparison covers both in detail.
Thymalin and thymulin
Thymalin is a thymus-derived peptide preparation from the Soviet era. In a study by the St. Petersburg institute that developed it, 266 older adults received thymalin, epithalamin or neither, and the authors reported fewer respiratory infections and lower death rates over six to eight years.[14] Those findings come from the developers and have not been confirmed by independent, modern trials. Our Khavinson bioregulators guide explains this research tradition. Thymulin, a zinc-dependent thymus hormone, has no published trials for immune support that we could find.
Why “boosting” immunity can backfire
A stronger immune response is not always better. Autoimmune diseases, allergies and some inflammatory conditions are immune responses aimed at the wrong target. That is why labels for thymosin alpha-1 abroad urge caution in autoimmune disease and with other immune-active drugs.[4] Products sold online also carry unknowns about purity, dose and sterility.[13]
Who should be especially careful
Some groups face more risk and less certainty with immune peptides:
- Children and pregnant or breastfeeding people: labels for thymosin alpha-1 abroad say it should not be used in children and is contraindicated in pregnancy and breastfeeding.[4]
- People with autoimmune disease: use must be weighed case by case, according to those same labels.[4]
- Transplant recipients and others on immune-suppressing drugs: an immune stimulant could work against medicines that are deliberately calming the immune system.[4]
- People with psoriasis or rosacea: LL-37 is part of the immune attack in many people with psoriasis, so adding more is not a logical choice.[15]
Questions for your clinician
- Am I up to date on the vaccines recommended for my age and health?
- Do my infections suggest an immune problem that should be tested?
- Could a sleep, nutrition or vitamin D issue be contributing?
- If I am considering a peptide, how might it interact with my conditions and medicines?
The bottom line
The best-supported ways to support immunity are recommended vaccines and enough sleep. Thymosin alpha-1 is the only immune peptide with a substantial trial record, and that record is mixed, with no benefit in its largest recent trials and no US approval. LL-37, thymalin and thymulin lack good evidence for immune support. Related reading: epitalon vs TA-65 and LL-37 vs defensins vs magainin.
This is general information, not medical advice.
